OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing antibody and nanobody nativeness for hit selection and humanization with AbNatiV
Aubin Ramon, Montader Ali, Misha Atkinson, et al.
Nature Machine Intelligence (2024) Vol. 6, Iss. 1, pp. 74-91
Open Access | Times Cited: 24

Showing 24 citing articles:

Prospects for the computational humanization of antibodies and nanobodies
G. Gordon, Matthew I. J. Raybould, Chi Yan Wong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9

For antibody sequence generative modeling, mixture models may be all you need
Jonathan Parkinson, Wei Wang
Bioinformatics (2024) Vol. 40, Iss. 5
Open Access | Times Cited: 6

Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Habib Bashour, Eva Smorodina, Matteo Pariset, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6

Molecular Modelling and Optimization of a High-Affinity Nanobody Targeting the Nipah Virus Fusion Protein Through In Silico Site-Directed Mutagenesis
Nyzar Mabeth O. Odchimar, Albert Neil G. Dulay, Fredmoore L. Orosco
Computational Biology and Chemistry (2025) Vol. 115, pp. 108354-108354
Closed Access

Anti-Drug Antibody Response to Therapeutic Antibodies and Potential Mitigation Strategies
Erin L. Howard, Melanie M. Goens, Leonardo Susta, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 299-299
Open Access

Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management
Akram N. Salah, Amr H. Hashem, Mohamed Bakr Zaki, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access

Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions
Michael Mullin, James McClory, Winston Haynes, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
Nehad S. El Salamouni, Jordan H. Cater, Lisanne M. Spenkelink, et al.
FEBS Open Bio (2024)
Open Access | Times Cited: 2

Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
Paul J. Carter, Valerie Quarmby
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 898-913
Closed Access | Times Cited: 2

Nanobody Engineering: Computational Modelling and Design for Biomedical and Therapeutic Applications
Nehad El Salamouni, Jordan H. Cater, Lisanne Spenkelink, et al.
(2024)
Open Access | Times Cited: 1

Specific features of a scaffolding antibody light chain
Johanna Trommer, Florian Lesniowski, Johannes Büchner, et al.
Protein Science (2024) Vol. 33, Iss. 5
Open Access | Times Cited: 1

Nanobody Engineering: Computational Modelling and Design for Biomedical and Therapeutic Applications
Nehad El Salamouni, Jordan H. Cater, Lisanne Spenkelink, et al.
(2024)
Open Access | Times Cited: 1

A comprehensive overview of recent advances in generative models for antibodies
Fanxu Meng, Na Zhou, Hu Guangchun, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2648-2660
Open Access | Times Cited: 1

On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality
Monica L. Fernández‐Quintero, Enrico Guarnera, Djordje Müsil, et al.
Protein Science (2024) Vol. 33, Iss. 11
Open Access | Times Cited: 1

Nanobodies: from high-throughput identification to therapeutic development
Peter C. Fridy, Michael P. Rout, Natalia E. Ketaren
Molecular & Cellular Proteomics (2024), pp. 100865-100865
Open Access | Times Cited: 1

Humatch - fast, gene-specific joint humanisation of antibody heavy and light chains
Lewis Chinery, Jeliazko R. Jeliazkov, Charlotte M. Deane
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1

50 years of antibody numbering schemes: a statistical and structural evaluation reveals key differences and limitations
Zirui Zhu, Katherine S. Olson, Thomas J. Magliery
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Single-Domain Antibodies—Novel Tools to Study and Treat Allergies
Ines Zettl, Clarissa Bauernfeind, Jessica Kollárová, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7602-7602
Open Access

Pep2Vec: An Interpretable Model for Peptide-MHC Presentation Prediction and Contaminant Identification in Ligandome Datasets
William John Thrift, Quade Broadwell, Jason Perera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

An adaptive autoregressive diffusion approach to design active humanized antibody and nanobody
Jian Ma, Fandi Wu, Tingyang Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Molecular dynamics and machine learning stratify motion-dependent activity profiles of S-layer destabilizing nanobodies
Adam J. Cecil, Adrià Sogues, Mukund Gurumurthi, et al.
PNAS Nexus (2024) Vol. 3, Iss. 12
Open Access

50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations
Zirui Zhu, Katherine S. Olson, Thomas J. Magliery
Antibodies (2024) Vol. 13, Iss. 4, pp. 99-99
Open Access

Nanobody–antigen interaction prediction with ensemble deep learning and prompt-based protein language models
Juntao Deng, Miao Gu, Pengyan Zhang, et al.
Nature Machine Intelligence (2024)
Closed Access

Page 1

Scroll to top